KMB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kimberly-Clark Corp (KMB) is not a strong buy at this moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company has a solid dividend growth history and is making strategic moves like the Kenvue acquisition, the technical indicators suggest a bearish trend, and the stock is currently oversold. Additionally, analysts' ratings and price target changes reflect mixed sentiment, with some concerns about sector fundamentals. Given the lack of strong proprietary trading signals and the current market sentiment, it would be prudent to hold off on buying at this time.
The technical indicators show a bearish trend. The MACD is negative and expanding downward (-1.39), the RSI is at 12.021, indicating the stock is oversold, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at S1: 99.219 and S2: 95.894, with resistance at R1: 109.981 and R2: 113.305. The stock is trading below its pivot point of 104.6, suggesting further downside risk.
Kimberly-Clark's acquisition of Kenvue for $48.7 billion is expected to generate $2 billion in cost synergies and solidify its dividend growth track record.
The company maintains a 54-year dividend growth history and a forward dividend yield of 3.5%.
Recent appointment of Francesco Tinto as Chief Information & Global Business Services Officer could enhance operational efficiency and support strategic initiatives.
Analysts have mixed ratings, with some lowering price targets due to concerns about sector fundamentals, potential oil and currency headwinds, and muted volume growth in consumer staples.
The stock has a 50% chance of declining further in the short term (-0.79% in the next day, -2.96% in the next week, -3.22% in the next month).
Technical indicators show a bearish trend, and the stock is currently oversold.
In Q4 2025, Kimberly-Clark's revenue dropped by -0.58% YoY to $4.08 billion. However, net income increased by 11.63% YoY to $499 million, and EPS rose by 11.94% YoY to 1.5. Gross margin improved slightly to 36.99% (+0.33% YoY). While profitability metrics are improving, the decline in revenue is a concern.
Analysts have mixed views on KMB. Recent price target changes include Wells Fargo raising its target to $110 from $105 with an Equal Weight rating, UBS raising its target to $110 from $107 with a Neutral rating, and BofA lowering its target to $130 from $148 but maintaining a Buy rating. Barclays and TD Cowen have lowered their targets, citing concerns about sector fundamentals and muted growth prospects.
